TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Integrativ Biomedicin Öckerman AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
341
|
311 | |
| Financial expenses |
1
|
0 | |
| Earnings before taxes |
147
|
-20 | |
| EBITDA |
81
|
-87 | |
| Total assets |
494
|
473 | |
| Current assets |
478
|
456 | |
| Current liabilities |
28
|
11 | |
| Equity capital |
453
|
454 | |
| - share capital |
67
|
67 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.7%
|
96.0% | |
| Turnover per employee |
341
|
311 | |
| Profit as a percentage of turnover |
43.1%
|
-6.4% | |
| Return on assets (ROA) |
30.0%
|
-4.2% | |
| Current ratio |
1707.1%
|
4145.5% | |
| Return on equity (ROE) |
32.5%
|
-4.4% | |
| Change turnover |
28
|
-12 | |
| Change turnover % |
-17%
|
9%
|
-4% |
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.